As the number of COVID-19 cases has risen above 300,000 in Africa, there is a growing concern for equitable and fair access to any approved vaccine targeting SARS-CoV-2, the virus behind the COVID-19 pandemic. Governments across the continent are now convening to...
Uncategorized
Category
Kansas Clinical Investigative Site Ready for COVID-19 Vaccine Clinical Trial
Kansas-based Heartland Research Associates, a clinical research center and investigatory site, has completed more than 300 major vaccine studies—they have now added a COVID-19 vaccine study to their portfolio as a pharmaceutical company opted them into a trial. The...
University of Miami-Originated IP the Basis for Prospective COVID-19 Vaccine
Research scientists from the University of Miami have teamed with North Carolina-based Heat Biologics to develop a vaccine for the coronavirus. Elite immunologists within the South Florida-based university are focusing on the biotech's gp96 platform designed to target...
University of Pennsylvania-Led Research Discovers Second Type of Schizophrenia
A multicenter research led by the University of Pennsylvania reveals that based on an in-depth analysis of over 300 patients, it would appear that there are two distinct neuroanatomical subtypes of schizophrenia. With the results published in the online...
University of Minnesota Designated Regional Treatment Center for COVID-19 Launching Three Clinical Trials
The University of Minnesota Medical School commenced a study to test remdesivir, the experimental drug originally developed for Ebola, to determine if it can be used on those hospitalized due to COVID-19. The university has been designated by the federal government as...
Global Autism Spectrum Disorder Centers on an Investigational Drug Called Balovaptan by Roche: Canadians Discuss
In Toronto, an international study is underway for an experimental drug for people with Autism Spectrum Disorder (ASD), and the community is divided on the use of the drug manufactured by the sponsor Hoffmann-La Roche. Called Balovaptan, the drug could potentially...
How Clinical Trial Sponsors Manage their Critical Documentation: A Recent Acquisition
Phlexglobal, a UK-based outsourced clinical trial master file service provider and software developer, has acquired Cunesoft, a niche Munich-based regulatory data and document management upstart from its shareholders, including Bayern Kapital, High-Tech Gründerfonds,...
Institute of Vaccines and Medical Biologicals (IVAC) Vietnam Sponsors Successful Flu Vaccine
The Institute of Vaccines and Medical Biologicals (IVAC) in Vietnam recently conducted a vaccine study concluding that a potential counter to pandemic threats from A(H5N1) influenza may also involve priming the target population with A(H5N1) vaccine, and after that...
Henry Ford Hospital Dermatology Research Probes Laser
A research team from Henry Ford Hospital recently suggested in a medical research paper that treating hidradenitis suppurativa more effectively could involve not one medication, but rather a multimodal approach including not only topical and systemic therapies, but...
New State-of-Art Clinical Research Business Park to Rise in High Point, North Carolina
North Carolina biotech entrepreneur Adnan Mjalli at Oasis Investment Group will develop a $425 million research park on 80 acres of newly annexed land in High Point. This development represents a new model of clinical research, where a confluence of infrastructure,...
The University of Birmingham with Ground-breaking Research Technique Assessing the Aggressiveness of Childhood Brain Tumors
About one-third of childhood cancer deaths in the UK result from brain cancers. The Brain Tumour Charity recently reported that the University of Birmingham, the clinical investigative site, developed a new personalized approach that can help clinicians give more...
Institute for Molecular Medicine on a Mission to Develop Alzheimer’s Vaccine Developed at Flinders University
A research team, including the Institute for Molecular Medicine and the University of California, Irvine (UCI), are in pursuit of a potential preventative treatment for dementia, which may proceed to clinical trials after successful preclinical research (animal...
CRO Clinipace Raises $4.2M in Quest for $10M and More Employees as They Continue to Grow
Tech-enabled clinical research organization (CRO) Clinipace is on a mission to raise $10 million based on a recent security filing and has secured $4.2 million to date from 16 investors. The funding represents a mix of debt and options. Additional Financings Earlier...
University of Minnesota Opens First-Ever U.S. Clinical Trial of Engineered iPSC-derived Cell Therapy for Blood Cancer
A new cancer trial has commenced at the M Health Fairview University of Minnesota Medical Center that leverages the groundbreaking research on stem cells and natural killer (NK) cells done at the Masonic Cancer Center and applies it to attack acute myeloid leukemia...
Principia Announces Positive Preliminary Data from Part B of Phase 2 Trial of PRN1008 for Pemphigus
Principia Biopharma announced positive results from part B of an ongoing phase 2 trial of PRN1008 for the treatment of pemphigus. The open label trial enrolled 27 patients with pemphigus (including both pemphigus vulgaris and pemphigus foliaceus) to evaluate PRN1008’s...
Isofol Announces Global Phase 3 AGENT Clinical Study Presentation at 2019 ESMO Congress
On Sept. 29, 2019, Isofol announced a poster presentation on their ongoing global Phase 3 AGENT clinical study in patients with metastatic colorectal cancer (mCRC). This will be presented at the 2019 European Society of Medical Oncology (ESMO) Congress held...
Clinical Trials of Texas Conducts Clinical Trial of Implantable Device for Type 1 Diabetes
Clinical Trials of Texas (CTT) is currently conducting is conducting a Type 1 diabetes focused trial centering on a new device—a censor with the core electronics placed under the skin in the upper arm. An adhesive patch secures the transmitter to the skin. This...
StemCell Inc. Receives FDA Warning for Manufacturing and Distributing Unapproved Products
The U.S. Food and Drug Administration has warned Stemell, Inc. (Stemell), of San Juan Capistrano, California, and its president and Chief Executive Officer, Peyman Taeidi, Ph.D., for manufacturing and distributing unapproved products derived from umbilical cord blood...
University of South Florida Participates in Phase III Clinical Trial Targeting Huntington’s Disease
University of South Florida (USF) is conducting a Phase III clinical trial for a drug that targets the genetic cause of Huntington’s disease (HD) which some describe as a mix of Parkinson’s disease, Lou Gehrig’s Disease, and Alzheimer’s. A USF neurologist, Dr. Juan...
NIH’s ‘All of Us’ Shows up in Milwaukee & Collaborates with Medical College of Wisconsin
The “All of Us” study is an NIH program that is seeking 1 million recruits nationwide obtaining various data from body measurement, blood pressure readings, and blood and urine sample that can be privately analyzed to accelerate health research. The office—a...